clinical trial · NCT03543189
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
H. Lee Moffitt Cancer Center and Research Institute·phase2·completed·n = 44
Prostate CancerProstate DiseaseNivolumabBrachytherapyExternal Beam Radiation TherapyAndrogen Deprivation Therapy
brief summary
The purpose of this study is to test the safety, tolerability, and effectiveness of the investigational drug nivolumab (Opdivo™) in combination with high dose radiation. Investigators also want to see if these study drugs help to delay the progression of prostate cancer.
started
Oct 3, 2018
primary completion
Jun 19, 2026
completion
Jun 19, 2026
last updated
Sep 16, 2026
official title
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol